查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1515450

PARP 抑制劑生物標記市場，按產品、服務、應用和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

PARP Inhibitor Biomarkers Market, By Product, By Services, By Application, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年 PARP 抑制劑生物標記市場規模為 9.158 億美元，2024 年至 2032 年複合年成長率為 8.80%。

PARP 抑制劑生物標記市場-市場動態

癌症管理和治療成本上升推動市場成長

管理和治療成本的不斷成長預計將支持市場擴張。例如，《柳葉刀地區衛生》雜誌 2022 年 10 月發表的一篇期刊論文報道了印度尋求全面結直腸癌治療的患者的治療減員和災難性費用。在納入的 226 名患者中，有 4 名患者失訪，20 名患者在接受治療計劃後六個月內去世。大腸直腸癌的治療費用平均為 407,508 印度盧比（印度盧比/5,340 美元）。患者的 PARP（中位數價值 330,277 印度盧比/4328 美元）是總費用的最大貢獻者。

PARP 抑制劑生物標記市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 8.80% 左右的複合年成長率成長

根據服務細分，預計 BRCA 1 和 2 測試類別將在 2023 年顯示最大的市場佔有率

基於應用細分，2023年乳癌類別為主導類型

按地區分類，北美是 2023 年的主要收入來源

PARP 抑制劑生物標記市場 - 細分分析：

全球 PARP 抑制劑生物標記市場根據產品、服務、應用和區域進行細分。

市場依產品分為兩類：試劑盒和檢測。試劑盒類別在市場上佔據主導地位，因為這些試劑盒用於測試和診斷與基因突變和變化相關的疾病。與遺傳性 DNA 突變相關的最常見疾病之一是乳癌。為了滿足對準確、高效診斷不斷成長的需求，市場主要參與者不斷致力於開發新的解決方案。 Myriad Genetics, Inc. 的 myChoice CDx 是經 FDA 批准的一項測試，用於確定患有同源重組缺陷 (HRD) 狀態的晚期卵巢癌個體。

根據應用，市場分為以下幾類：乳癌、卵巢癌和其他。腫瘤學類別在市場中佔據主導地位，並可能在預測期內保持其主導地位。與 BRCA1 或 BRCA2 基因突變引起的基因改變相關的乳癌發生率的增加被認為是該片段擴張的原因。世界衛生組織 2023 年 2 月的文章指出，預計到 2040 年，將有 250 萬人受到乳癌的影響。各國。儘管如此，存活率差異很大，大部分死亡發生在低收入和中等收入國家。過去三十年來，高收入國家的乳癌死亡率顯著下降，而低收入和中等收入國家則沒有類似的下降。

PARP 抑制劑生物標記市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區、中東和非洲地區。這些區域根據開展業務的國家進一步分類。

在預測期內，北美預計將在 PARP 抑制劑生物標記全球市場中佔據最大佔有率。這一高比例可歸因於癌症治療成本的上升、基因組技術的進步以及癌症盛行率的上升。美國癌症協會的一篇文章預計，到 2022 年，美國將有約 609,360 人因癌症死亡，新診斷癌症病例將超過 190 萬例。因此，隨著癌症變得越來越普遍，越來越多的患者使用基因測試來識別 PARP 抑制劑治療的潛在候選者，這推高了生物標記測試的成本。

此外，由於包括 Thermo Fisher Scientific, Inc.、QIAGEN 和 Illumina 在內的重要區域和國家市場參與者的存在，預計亞太地區 PARP 抑制劑生物標記市場將以全球最快的速度擴張。成長也將受到以下因素的推動：政府改善醫療基礎設施的舉措、人均收入的增加導致更多地採用診斷和治療產品，以及整個地區對PARP 抑制劑生物標記技術的投資大幅增加。在預測期內，由於具有新先進功能的智慧型手機的使用不斷增加，中國、日本和印度等新興國家預計將推動市場擴張。

PARP 抑制劑生物標記市場-競爭格局：

該領域的領導企業包括 Ambry Genetics、Myriad Genetics, Inc.、Thermo Fisher Scientific, Inc. 和 Illumina, Inc.。為了應對激烈的競爭，這些公司轉向了各種策略，包括合作夥伴關係、併購以及創造新產品。

最近的發展：

2024 年 2 月：基因檢測與精準醫療新創公司 Myriad Genetics, Inc. 成功收購了 Intermountain Health 旗下 Intermountain Precision Genomics (IPG) 實驗室集團的多項資產。此次收購包括他位於猶他州聖喬治的 CLIA 認證實驗室，以及精密流體測試和精密腫瘤學測試。

2024 年 1 月：基因檢測和精準醫療製造商 Myriad Genetics, Inc. 已表示支持 ASCO 和 SSO 關於乳癌患者種系檢測的指南。該公司強調 ASCO-SSO 指南的更新是遺傳學融入患者治療的重要一步。

2023 年 1 月：尋找前列腺癌對 PARP 藥物抗藥性的新指標在很大程度上是透過 CRISPR 技術實現的。研究人員利用全基因組 CRISPR 敲除篩選來研究不同的基因改變如何影響 PARP 藥物的有效性。 MMS22L 基因的鑑定是這些研究中值得注意的發現，該基因被刪除後可顯著提高對 PARP 抑制劑的敏感性。

目錄

第 1 章：PARP 抑制劑生物標記市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • PARP 抑制劑生物標記市場片段（按產品）
    • PARP 抑制劑生物標記市場片段（按服務）
    • PARP 抑制劑生物標記市場片段（按應用）
    • PARP 抑制劑生物標記市場片段（按國家/地區）
    • PARP 抑制劑生物標記市場片段（按地區）
  • 競爭洞察

第 3 章：PARP 抑制劑生物標記主要市場趨勢

  • PARP 抑制劑生物標記市場促進因素
    • 市場促進因素的影響分析
  • PARP 抑制劑生物標記市場限制
    • 市場限制影響分析
  • PARP 抑制劑生物標記市場機會
  • PARP 抑制劑生物標記市場未來趨勢

第 4 章：PARP 抑制劑生物標記產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：PARP 抑制劑生物標記市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：PARP 抑制劑生物標記市場格局

  • 2023 年 PARP 抑制劑生物標記市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：PARP 抑制劑生物標記市場 - 按產品

  • 概述
    • 按產品分類的細分市場佔有率分析
    • 套件
    • 化驗

第 8 章：PARP 抑制劑生物標記市場 - 按服務

  • 概述
    • 按服務分類的細分市場佔有率分析
    • BRCA 1 和 2 測試
    • 人力資源開發測試
    • HRR測試
    • 其他

第 9 章：PARP 抑制劑生物標記市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 乳癌
    • 卵巢癌
    • 其他

第 10 章：PARP 抑制劑生物標記市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • PARP 抑制劑生物標記北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品）
    • 北美市場規模和預測（按服務）
    • 北美市場規模和預測（按應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • PARP 抑制劑生物標記歐洲主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按產品）
    • 歐洲市場規模和預測（按服務）
    • 歐洲市場規模和預測（按應用）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • PARP抑制劑生物標記物亞太地區主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按產品）
    • 亞太地區市場規模與預測（按服務）
    • 亞太地區市場規模與預測（按應用）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • PARP 抑制劑生物標記拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品）
    • 拉丁美洲市場規模與預測（按服務）
    • 拉丁美洲市場規模與預測（按應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • PARP 抑制劑生物標記物中東和非洲主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品）
    • 中東和非洲市場規模及預測（按服務）
    • 中東和非洲市場規模及預測（按應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - PARP 抑制劑生物標記產業

  • 競爭儀表板
  • 公司簡介
    • Myriad Genetics, Inc.
    • CENTOGENE NV
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • Agilent Technologies, Inc.
    • Amoy Diagnostics Co., Ltd.
    • Invitae Corporation
    • Ambry Genetics
    • NeoGenomics Laboratories.
    • QIAGEN.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV3187

REPORT HIGHLIGHT

PARP Inhibitor Biomarkers Market size was valued at USD 915.8 Million in 2023, expanding at a CAGR of 8.80% from 2024 to 2032.

An agent that inhibits the cellular PARP enzyme. When DNA is broken, PARP aids in its repair. Numerous factors, including radiation, UV light exposure, some anticancer medications, and other compounds found in the environment, can harm DNA. In cancer treatment, PARP blocking may assist in preventing cancer cells from repairing their damaged DNA, which would ultimately lead to their demise. Known also as poly (ADP-ribose) polymerase inhibitors, PARP inhibitors are a class of targeted medicine.

PARP Inhibitor Biomarkers Market- Market Dynamics

Rising Costs for Cancer Management and Treatment to Propel Market Growth

Growing costs for the management and treatment of are anticipated to support market expansion. For instance, a journal paper from October 2022 in the Lancet Regional Health reported on treatment attrition and catastrophic costs for patients seeking full colorectal cancer therapy in India. Of the 226 patients that were included, four were lost to follow-up and 20 passed away within six months of receiving a treatment plan. Treatment for colorectal cancer cost, on average, 407,508 Indian Rupees (INR/5340 USD). The patient's PARP (median 330,277 INR/4328 USD) was the largest contributor to this total cost.

PARP Inhibitor Biomarkers Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.80 % over the forecast period (2024-2032)

Based on service segmentation, the BRCA 1 & 2 testing category was predicted to show maximum market share in the year 2023

Based on application segmentation, the breast cancer category was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

PARP Inhibitor Biomarkers Market- Segmentation Analysis:

The Global PARP Inhibitor Biomarkers Market is segmented on the basis of Product, Service, Application, and Region.

The market is divided into two categories based on product: Kits and Assays. The kits category dominates the market because these kits are used to test for and diagnose diseases associated with mutations and changes in genes. One of the most prevalent diseases linked to inherited DNA mutations is breast cancer. In order to address the growing demand for accurate and efficient diagnostics, major players in the market are continuously concentrating on developing new solutions. One FDA-approved test for determining individuals with advanced ovarian cancer who have a positive homologous recombination deficiency (HRD) status is myChoice CDx from Myriad Genetics, Inc.

The market is divided into the following categories based on application: Breast Cancer, Ovarian Cancer, and Others. The oncology category dominates the market and is likely to maintain its dominance during the forecast period. The increasing frequency of breast cancer linked to gene alterations brought on by BRCA1 or BRCA2 genetic mutations is thought to be the reason for the segment's expansion. The WHO article from February 2023 states that It is predicted that 2.5 million people would be affected by breast cancer by 2040. Breast cancer is the most common type of cancer in women and the main cause of cancer-related deaths in women in 95% of the world's countries. In spite of this, survival rates differ greatly, and the bulk of deaths take place in low- and middle-income nations. Over the past three decades, breast cancer mortality rates have significantly decreased in high-income countries, whereas low- and middle-income countries have not seen a comparable decline.

PARP Inhibitor Biomarkers Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for PARP inhibitor biomarkers. This high percentage can be attributed to rising cancer treatment costs, advances in genomic technologies, and rising cancer prevalence. An article from the American Cancer Society projects that in 2022, there will be about 609,360 cancer-related deaths and over 1.9 million new cancer cases diagnosed in the United States. As a result, as cancer is becoming more common, more patients are using genetic testing to identify potential candidates for PARP inhibitor therapy, which is driving up the cost of biomarker testing.

In addition, the PARP inhibitor biomarkers market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific ascribed to the existence of significant regional and national market participants including Thermo Fisher Scientific, Inc., QIAGEN, and Illumina, Inc. The region's growth is also expected to be fueled by government initiatives to improve healthcare infrastructure, a rise in per capita income that leads to a greater adoption of diagnostic and therapy products, and significantly increased investments in PARP inhibitor biomarkers technologies throughout the region. Over the course of the forecast period, emerging nations like China, Japan, and India are expected to fuel the market expansion due to the growing usage of smartphones with new advanced features.

PARP Inhibitor Biomarkers Market- Competitive Landscape:

Among the leading businesses in the field are Ambry Genetics, Myriad Genetics, Inc., Thermo Fisher Scientific, Inc., and Illumina, Inc. A highly concentrated market is indicated by the fact that a small group of producers have the majority of the market share. To counter the intense competition, these companies have turned to a variety of strategies, including partnerships, mergers and acquisitions, and the creation of new products.

Recent Developments:

February 2024: The genetic testing and precision medicine startup Myriad Genetics, Inc. has successfully acquired a number of assets from Intermountain Health's Intermountain Precision Genomics (IPG) laboratory group. The purchase includes his CLIA-certified laboratory in St. George, Utah, as well as Precision Fluid Testing and Precision Oncology Testing.

January 2024: ASCO and SSO guidelines about germline testing for breast cancer patients are something that Myriad Genetics, Inc., a manufacturer of genetic testing and precision medicine, has stated its support for. The business highlights the updating of the ASCO-SSO guidelines as a major step forward in the integration of genetics into patient treatment.

January 2023: Finding novel indicators for prostate cancer resistance to PARP medicines is made possible in large part by CRISPR technology. Researchers have used genome-wide CRISPR knockout screens to investigate the ways in which distinct genetic alterations affect PARP drug effectiveness. The identification of MMS22L, a gene that, when deleted, dramatically improves the sensitivity to PARP inhibitors, is a noteworthy finding from these investigations.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PARP INHIBITOR BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Myriad Genetics, Inc.

CENTOGENE N.V.

Thermo Fisher Scientific, Inc.

Illumina, Inc.

Agilent Technologies, Inc.

Amoy Diagnostics Co., Ltd.

Invitae Corporation

Ambry Genetics

NeoGenomics Laboratories.

QIAGEN

Others

GLOBAL PARP INHIBITOR BIOMARKERS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Kits
  • Assays

GLOBAL PARP INHIBITOR BIOMARKERS MARKET, BY SERVICE- MARKET ANALYSIS, 2019 - 2032

  • BRCA 1 & 2 Testing
  • HRD Testing
  • HRR Testing
  • Others

GLOBAL PARP INHIBITOR BIOMARKERS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Breast Cancer
  • Ovarian Cancer
  • Others

GLOBAL PARP INHIBITOR BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. PARP Inhibitor Biomarkers Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. PARP Inhibitor Biomarkers Market Snippet by Product
    • 2.1.2. PARP Inhibitor Biomarkers Market Snippet by Services
    • 2.1.3. PARP Inhibitor Biomarkers Market Snippet by Application
    • 2.1.4. PARP Inhibitor Biomarkers Market Snippet by Country
    • 2.1.5. PARP Inhibitor Biomarkers Market Snippet by Region
  • 2.2. Competitive Insights

3. PARP Inhibitor Biomarkers Key Market Trends

  • 3.1. PARP Inhibitor Biomarkers Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. PARP Inhibitor Biomarkers Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. PARP Inhibitor Biomarkers Market Opportunities
  • 3.4. PARP Inhibitor Biomarkers Market Future Trends

4. PARP Inhibitor Biomarkers Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. PARP Inhibitor Biomarkers Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. PARP Inhibitor Biomarkers Market Landscape

  • 6.1. PARP Inhibitor Biomarkers Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. PARP Inhibitor Biomarkers Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Kits
    • 7.1.3. Assays

8. PARP Inhibitor Biomarkers Market - By Services

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Services, 2023 & 2032 (%)
    • 8.1.2. BRCA 1 & 2 Testing
    • 8.1.3. HRD Testing
    • 8.1.4. HRR Testing
    • 8.1.5. Others

9. PARP Inhibitor Biomarkers Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Breast Cancer
    • 9.1.3. Ovarian Cancer
    • 9.1.4. Others

10. PARP Inhibitor Biomarkers Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. PARP Inhibitor Biomarkers Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. PARP Inhibitor Biomarkers Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. PARP Inhibitor Biomarkers Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. PARP Inhibitor Biomarkers Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. PARP Inhibitor Biomarkers Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- PARP Inhibitor Biomarkers Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Myriad Genetics, Inc.
    • 11.2.2. CENTOGENE N.V.
    • 11.2.3. Thermo Fisher Scientific, Inc.
    • 11.2.4. Illumina, Inc.
    • 11.2.5. Agilent Technologies, Inc.
    • 11.2.6. Amoy Diagnostics Co., Ltd.
    • 11.2.7. Invitae Corporation
    • 11.2.8. Ambry Genetics
    • 11.2.9. NeoGenomics Laboratories.
    • 11.2.10. QIAGEN.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE PARP Inhibitor Biomarkers Market: Product Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global PARP Inhibitor Biomarkers Market, by Product 2019-2032 (USD Million)
  • TABLE PARP Inhibitor Biomarkers Market: Services Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Services
  • TABLE Global PARP Inhibitor Biomarkers Market, by Services 2019-2032 (USD Million)
  • TABLE PARP Inhibitor Biomarkers Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global PARP Inhibitor Biomarkers Market, by Application 2019-2032 (USD Million)
  • TABLE PARP Inhibitor Biomarkers Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global PARP Inhibitor Biomarkers Market, by Region 2019-2032 (USD Million)
  • TABLE North America PARP Inhibitor Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE North America PARP Inhibitor Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE North America PARP Inhibitor Biomarkers Market, by Services, 2019-2032 (USD Million)
  • TABLE North America PARP Inhibitor Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe PARP Inhibitor Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe PARP Inhibitor Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE Europe PARP Inhibitor Biomarkers Market, by Services, 2019-2032 (USD Million)
  • TABLE Europe PARP Inhibitor Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific PARP Inhibitor Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific PARP Inhibitor Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE Asia Pacific PARP Inhibitor Biomarkers Market, by Services, 2019-2032 (USD Million)
  • TABLE Asia Pacific PARP Inhibitor Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America PARP Inhibitor Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America PARP Inhibitor Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE Latin America PARP Inhibitor Biomarkers Market, by Services, 2019-2032 (USD Million)
  • TABLE Latin America PARP Inhibitor Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PARP Inhibitor Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PARP Inhibitor Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PARP Inhibitor Biomarkers Market, by Services, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PARP Inhibitor Biomarkers Market, by Application, 2019-2032 (USD Million)

List of Figures

  • FIGURE PARP Inhibitor Biomarkers Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product segment market share analysis, 2023 & 2032
  • FIGURE Product segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Services segment market share analysis, 2023 & 2032
  • FIGURE Services segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America PARP Inhibitor Biomarkers Market share and leading players, 2023
  • FIGURE Europe PARP Inhibitor Biomarkers Market share and leading players, 2023
  • FIGURE Asia Pacific PARP Inhibitor Biomarkers Market share and leading players, 2023
  • FIGURE Latin America PARP Inhibitor Biomarkers Market share and leading players, 2023
  • FIGURE Middle East and Africa PARP Inhibitor Biomarkers Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe PARP Inhibitor Biomarkers Market share analysis by country, 2023
  • FIGURE Germany PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific PARP Inhibitor Biomarkers Market share analysis by country, 2023
  • FIGURE India PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America PARP Inhibitor Biomarkers Market share analysis by country, 2023
  • FIGURE Brazil PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa PARP Inhibitor Biomarkers Market share analysis by country, 2023
  • FIGURE Saudi Arabia PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)